171 related articles for article (PubMed ID: 34497833)
1. Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study.
Gao J; Huang X; Di W; Dong X; Gou W; Shi H; Wang Z; Dietl A; Grill S; Hund M
Front Cardiovasc Med; 2021; 8():602560. PubMed ID: 34497833
[TBL] [Abstract][Full Text] [Related]
2. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
[TBL] [Abstract][Full Text] [Related]
3. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
[TBL] [Abstract][Full Text] [Related]
4. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
Kumar N; Das V; Agarwal A; Agrawal S
AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
[TBL] [Abstract][Full Text] [Related]
5. A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk.
Chirilă CN; Mărginean C; Ghiga DV; Voidăzan S; Chirilă PM; Gliga ML
Children (Basel); 2024 Apr; 11(4):. PubMed ID: 38671685
[TBL] [Abstract][Full Text] [Related]
6. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
Andersen LLT; Helt A; Sperling L; Overgaard M
J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
[TBL] [Abstract][Full Text] [Related]
7. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
[TBL] [Abstract][Full Text] [Related]
9. Plasma sFlt-1/PlGF ratio of 11.5 multiples of median predicts preeclampsia with severe features within two weeks of testing.
Espinoza J; Calsavara VF; Kilpatrick S; Rana S; Costantine MM; Boggess K; Wylie BJ; Moore Simas TA; Louis JM; Gaw SL; Murtha A; Wiegand S; Gollin Y; Singh D; Silver RM; Durie DE; Panda B; Norwitz ER; Burd I; Plunkett B; Scott RK; Lemoine E; Thadhani R; Karumanchi SA
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38825028
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.
Dröge LA; Perschel FH; Stütz N; Gafron A; Frank L; Busjahn A; Henrich W; Verlohren S
Hypertension; 2021 Feb; 77(2):461-471. PubMed ID: 33280406
[TBL] [Abstract][Full Text] [Related]
11. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
[TBL] [Abstract][Full Text] [Related]
12. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
Shinohara S; Uchida Y; Kasai M; Sunami R
Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study.
Ohkuchi A; Masuyama H; Yamamoto T; Kikuchi T; Taguchi N; Wolf C; Saito S
Hypertens Res; 2021 Jul; 44(7):822-829. PubMed ID: 33594274
[TBL] [Abstract][Full Text] [Related]
14. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
Schlembach D; Hund M; Schroer A; Wolf C
BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia.
Binder J; Palmrich P; Pateisky P; Kalafat E; Kuessel L; Zeisler H; Munkhbaatar M; Windsperger K; Thilaganathan B; Khalil A
Hypertension; 2020 Jul; 76(1):176-183. PubMed ID: 32450740
[TBL] [Abstract][Full Text] [Related]
16. sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.
Hodel M; Blank PR; Marty P; Lapaire O
Dis Markers; 2019; 2019():4096847. PubMed ID: 31485276
[TBL] [Abstract][Full Text] [Related]
17. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
[TBL] [Abstract][Full Text] [Related]
18. Prediction of adverse maternal outcomes of early severe preeclampsia.
Mirkovic L; Tulic I; Stankovic S; Soldatovic I
Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis.
Lim S; Li W; Kemper J; Nguyen A; Mol BW; Reddy M
Obstet Gynecol; 2021 Jan; 137(1):72-81. PubMed ID: 33278298
[TBL] [Abstract][Full Text] [Related]
20. An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia.
Hassan MF; Rund NM; Salama AH
Obstet Gynecol Int; 2013; 2013():202346. PubMed ID: 24367379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
